Aging-Associated Cardiovascular Changes and Their Relationship to Heart Failure

Heart Failure Clinics

Volumn 8, Issue 1, 2012, Pages 143-164

  Strait, James B ^a   Lakatta, Edward G ^b  

^a HARBOR HOSPITAL   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Cardiac function; Cardiac reserve; Cardiovascular aging; Heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

AGING; ARTERIAL STIFFNESS; ARTERY WALL; ATHEROSCLEROSIS; BLOOD PRESSURE VARIABILITY; BLOOD VESSEL TONE; CALCIUM CONDUCTANCE; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL (TOPIC); CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DISEASE ASSOCIATION; DYSPNEA; ELECTROCARDIOGRAM; EXERCISE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART CONDUCTION; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART OUTPUT; HEART PROTECTION; HEART RATE AND RHYTHM; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; ISCHEMIC CARDIOMYOPATHY; ISCHEMIC PRECONDITIONING; NONHUMAN; PHYSICAL ACTIVITY; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; STROKE; SYMPATHETIC INNERVATION; SYSTEMIC DISEASE; SYSTOLIC HYPERTENSION;

AGING; CARDIOVASCULAR SYSTEM; DISEASE PROGRESSION; HEART FAILURE; HUMANS; PROGNOSIS; RISK FACTORS; VENTRICULAR FUNCTION;

EID: 82955249843     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2011.08.011     Document Type: Review

References (87)

1. Writing Group Members, Lloyd-Jones D., Adams R.J., et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010, 121(7):e46-e215.
2. Thomas S., Rich M. Epidemiology, pathophysiology, and prognosis of heart failure in the elderly. Heart Fail Clin 2007, 3(4):381-387.
3. Najjar S.S., Gerstenblith G., Lakatta E.G. Aging and the Cardiovascular System 2007, 2439-2451. Cardiovascular Medicine, Springer London, London. J.T. Willerson, H.J. Wellens, J.N. Cohn (Eds.).
4. Jessup M., Abraham W.T., Casey D.E., et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009, 119(14):1977-2016.
5. Chen W., Frangogiannis N.G. The role of inflammatory and fibrogenic pathways in heart failure associated with aging. Heart Fail Rev 2010, 15(5):415-422. 1-8.
6. Lakatta E.G., Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease. Circulation 2003, 107(2):346-354.
7. Scholz D.G., Kitzman D.W., Hagen P.T., et al. Age-related changes in normal human hearts during the first 10 decades of life. Part I (Growth): a quantitative anatomic study of 200 specimens from subjects from birth to 19 years old. Mayo Clin Proc 1988, 63(2):126-136.
8. Gerstenblith G., Frederiksen J., Yin F., et al. Echocardiographic assessment of a normal adult aging population. Circulation 1977, 56(2):273-278.
9. Olivetti G., Melissari M., Capasso J.M., et al. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res 1991, 68(6):1560-1568.
10. Hees P.S., Fleg J.L., Lakatta E.G., et al. Left ventricular remodeling with age in normal men versus women: novel insights using three-dimensional magnetic resonance imaging. Am J Cardiol 2002, 90(11):1231-1236.
11. Linzbach A.J., Akuamoa-Boateng E. Klin Wochenschr 1973, 51(4):156-163. [in German].
12. Khouri M.G., Maurer M.S., El-Khoury Rumbarger L. Assessment of age-related changes in left ventricular structure and function by freehand three-dimensional echocardiography. Am J Geriatr Cardiol 2005, 14(3):118-125.
13. Dannenberg A.L., Levy D., Garrison R.J. Impact of age on echocardiographic left ventricular mass in a healthy population (the Framingham Study). Am J Cardiol 1989, 64(16):1066-1068.
14. Fleg J.L., Lakatta E.G. Normal Aging of the Cardiovascular System. Chapter in Cardiovascular Disease in the Elderly 2008, 1-43. CRC Press, Boca Raton (FL). 4th edition. W. Aronow, M.W. Rich, J.L. Fleg (Eds.).
15. Schulman S.P., Lakatta E.G., Fleg J.L., et al. Age-related decline in left ventricular filling at rest and exercise. Am J Physiol 1992, 263(6 Pt 2):H1932-H1938.
16. Fleg J.L., Lakatta E.G. Role of muscle loss in the age-associated reduction in VO2 max. J Appl Physiol 1988, 65(3):1147-1151.
17. Fleg J.L., Morrell C.H., Bos A.G., et al. Accelerated longitudinal decline of aerobic capacity in healthy older adults. Circulation 2005, 112(5):674-682.
18. Le Blanc P.R., Rakusan K. Effects of age and isoproterenol on the cardiac output and regional blood flow in the rat. Can J Cardiol 1987, 3(5):246-250.
19. Rakusan K., Blahitka J. Cardiac output distribution in rats measured by injection of radioactive microspheres via cardiac puncture. Can J Physiol Pharmacol 1974, 52(2):230-235.
20. Miyatake K., Okamoto M., Kinoshita N., et al. Augmentation of atrial contribution to left ventricular inflow with aging as assessed by intracardiac Doppler flowmetry. Am J Cardiol 1984, 53(4):586-589.
21. Bryg R.J., Williams G.A., Labovitz A.J. Effect of aging on left ventricular diastolic filling in normal subjects. Am J Cardiol 1987, 59(9):971-974.
22. Spina R.J., Turner M.J., Ehsani A.A. Beta-adrenergic-mediated improvement in left ventricular function by exercise training in older men. Am J Physiol 1998, 274(2 Pt 2):H397-H404.
23. Tan Y., Wenzelburger F., Lee E., et al. The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. J Am Coll Cardiol 2009, 54(1):36.
24. Tarasov K.V., Sanna S., Scuteri A., et al. COL4A1 is associated with arterial stiffness by genome-wide association scan. Circ Cardiovasc Genet 2009, 2(2):151-158.
25. Hiss R.G., Lamb L.E. Electrocardiographic findings in 122,043 individuals. Circulation 1962, 25:947-961.
26. Fleg J.L., Das D.N., Wright J., et al. Age-associated changes in the components of atrioventricular conduction in apparently healthy volunteers. J Gerontol 1990, 45(3):M95-M100.
27. Golden G.S., Golden L.H. The " Nona" electrocardiogram: findings in 100 patients of the 90 plus age group. J Am Geriatr Soc 1974, 22(7):329-332.
28. Harlan W.R., Graybiel A., Mitchell R.E., et al. Serial electrocardiograms: their reliability and prognostic validity during a 24-yr. period. J Chronic Dis 1967, 20(11):853-867.
29. Mihalick M.J., Fisch C. Electrocardiographic findings in the aged. Am Heart J 1974, 87(1):117-128.
30. Manolio T.A., Furberg C.D., Rautaharju P.M., et al. Cardiac arrhythmias on 24-h ambulatory electrocardiography in older women and men: the Cardiovascular Health Study. J Am Coll Cardiol 1994, 23(4):916-925.
31. Fleg J.L., Kennedy H.L. Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory electrocardiography. Chest 1982, 81(3):302-307.
32. Fisch C. Introduction: chronic ventricular arrhythmias-a major unresolved health problem. Heart Lung 1981, 10(3):451-454.
33. Lakatta E.G., Sollott S.J. Perspectives on mammalian cardiovascular aging: humans to molecules. Comp Biochem Physiol A Mol Integr Physiol 2002, 132(4):699-721.
34. Janczewski A.M., Spurgeon H.A., Lakatta E.G. Action potential prolongation in cardiac myocytes of old rats is an adaptation to sustain youthful intracellular Ca2+ regulation. J Mol Cell Cardiol 2002, 34(6):641-648.
35. Lakatta E. Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons. Heart Fail Rev 2002, 7(1):29-49.
36. Lakatta E.G., Sollott S.J., Pepe S. The old heart: operating on the edge. Novartis FoundSymp 2001, 235:172-196. [discussion: 196-201, 217-20].
37. Lakatta E.G. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993, 73(2):413-467.
38. Lakatta E.G. Deficient neuroendocrine regulation of the cardiovascular system with advancing age in healthy humans. Circulation 1993, 87(2):631-636.
39. Esler M.D., Turner A.G., Kaye D.M., et al. Aging effects on human sympathetic neuronal function. Am J Physiol 1995, 268(1 Pt 2):R278-R285.
40. Lakatta E. Cardiovascular aging research: the next horizons. J Am Geriatr Soc 1999, 47(5):613-625.
41. Cigola E., Kajstura J., Li B., et al. Angiotensin II activates programmed myocyte cell death in vitro. Exp Cell Res 1997, 231(2):363-371.
42. Sadoshima J., Xu Y., Slayter H.S., et al. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993, 75(5):977-984.
43. Cave A.C., Brewer A.C., Narayanapanicker A., et al. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006, 8(5-6):691-728.
44. Lakatta E.G., Wang M., Najjar S.S. Arterial aging and subclinical arterial disease are fundamentally intertwined at macroscopic and molecular levels. Med Clin North Am 2009, 93(3):583-604. Table of Contents.
45. Farasat S.M., Morrell C.H., Scuteri A., et al. Pulse pressure is inversely related to aortic root diameter implications for the pathogenesis of systolic hypertension. Hypertension 2008, 51(2):196-202.
46. Nagai Y., Metter E., Earley C., et al. Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia. Circulation 1998, 98(15):1504-1509.
47. Ungvari Z., Kaley G., de Cabo R., et al. Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci 2010, 65(10):1028-1041.
48. Zieman S.J., Melenovsky V., Kass D.A. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005, 25(5):932-943.
49. Lakatta E.G., Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a " set up" for vascular disease. Circulation 2003, 107(1):139-146.
50. Semba R.D., Najjar S.S., Sun K., et al. Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults. Am J Hypertens 2009, 22(1):74-79.
51. Csiszar A., Wang M., Lakatta E.G., et al. Inflammation and endothelial dysfunction during aging: role of NF-kappaB. J Appl Physiol 2008, 105(4):1333-1341.
52. Tschudi M.R., Barton M., Bersinger N.A., et al. Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest 1996, 98(4):899-905.
53. Cernadas M.R., Sánchez de Miguel L., García-Durán M., et al. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ Res 1998, 83(3):279-286.
54. Wang M., Takagi G., Asai K., et al. Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates. Hypertension 2003, 41(6):1308-1316.
55. Wang M., Monticone R.E., Lakatta E.G. Arterial aging: a journey into subclinical arterial disease. Curr Opin Nephrol Hypertens 2010, 19(2):201-207.
56. Jiang L., Wang M., Zhang J., et al. Increased aortic calpain-1 activity mediates age-associated angiotensin II signaling of vascular smooth muscle cells. PLoS One 2008, 3(5):e2231.
57. Wang M., Zhao D., Spinetti G., et al. Matrix metalloproteinase 2 activation of transforming growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged arterial wall. Arterioscler Thromb Vasc Biol 2006, 26(7):1503-1509.
58. Wang M., Zhang J., Walker S.J., et al. Involvement of NADPH oxidase in age-associated cardiac remodeling. J Mol Cell Cardiol 2010, 48(4):765-772.
59. Tanaka H., Dinenno F.A., Monahan K.D., et al. Aging, habitual exercise, and dynamic arterial compliance. Circulation 2000, 102(11):1270-1275.
60. Roman M.J., Devereux R.B., Kizer J.R., et al. High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. J Am Coll Cardiol 2009, 54(18):1730-1734.
61. Vaitkevicius P.V., Fleg J.L., Engel J.H., et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 1993, 88(4 Pt 1):1456-1462.
62. Mitchell G.F., Parise H., Benjamin E.J., et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension 2004, 43(6):1239-1245.
63. Williams B., Lacy P.S. Central haemodynamics and clinical outcomes: going beyond brachial blood pressure?. Eur Heart J 2010, 31(15):1819-1822.
64. Pearson T., Mensah G., Alexander R. Markers of inflammation and cardiovascular disease application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107(3):499-511.
65. Najjar S., Scuteri A., Shetty V., et al. Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol 2008, 51(14):1377.
66. Chantler P.D., Lakatta E.G., Najjar S.S. Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise. J Appl Physiol 2008, 105(4):1342-1351.
67. Lakatta E.G. Cardiac muscle changes in senescence. Annu Rev Physiol 1987, 49:519-531.
68. Hees P.S., Fleg J.L., Mirza Z.A., et al. Effects of normal aging on left ventricular lusitropic, inotropic, and chronotropic responses to dobutamine. J Am Coll Cardiol 2006, 47(7):1440-1447.
69. Asanoi H., Sasayama S., Kameyama T. Ventriculoarterial coupling in normal and failing heart in humans. Circ Res 1989, 65(2):483-493.
70. Lam C.S.P., Roger V.L., Rodeheffer R.J., et al. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 2007, 115(15):1982-1990.
71. Lakatta E.G. Arterial aging is risky. J Appl Physiol 2008, 105(4):1321-1322.
72. Nussbacher A., Gerstenblith G., O'Connor F.C., et al. Hemodynamic effects of unloading the old heart. Am J Physiol 1999, 277(5 Pt 2):H1863-H1871.
73. Cohen-Solal A., Faraggi M., Czitrom D., et al. Left ventricular-arterial system coupling at peak exercise in dilated nonischemic cardiomyopathy. Chest 1998, 113(4):870-877.
74. Borlaug B.A., Melenovsky V., Russell S.D., et al. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 2006, 114(20):2138-2147.
75. Kitzman D.W., Higginbotham M.B., Cobb F.R., et al. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991, 17(5):1065-1072.
76. Fleg J.L. Can exercise conditioning be effective in older heart failure patients?. Heart Fail Rev 2002, 7(1):99-103.
77. Fleg J.L., O'Connor F., Gerstenblith G., et al. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol 1995, 78(3):890-900.
78. Bergmann O., Bhardwaj R.D., Bernard S., et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324(5923):98-102.
79. Kajstura J., Urbanek K., Perl S., et al. Cardiomyogenesis in the adult human heart. Circ Res 2010, 107(2):305-315.
80. Urbanek K., Torella D., Sheikh F., et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A 2005, 102(24):8692-8697.
81. Wong L.S., van der Harst P., de Boer R.A., et al. Aging, telomeres and heart failure. Heart Fail Rev 2010, 15(5):479-486.
82. Torella D., Rota M., Nurzynska D., et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res 2004, 94(4):514-524.
83. Gonzalez A., Rota M., Nurzynska D., et al. Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res 2008, 102(5):597-606.
84. Juhaszova M., Rabuel C., Zorov D.B., et al. Protection in the aged heart: preventing the heart-break of old age?. Cardiovasc Res 2005, 66(2):233-244.
85. Najjar S. Evolving insights into the pathophysiology of heart failure with preserved ejection fraction. Curr Cardiovasc Risk Rep 2009, 3(5):374-379.
86. Dulin B.R., Haas S.J., Abraham W.T., et al. Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of >12,000 patients in large-scale clinical trials. Am J Cardiol 2005, 95(7):896-898.
87. Massie B.M., Carson P.E., McMurray J.J., et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008, 359(23):2456-2467.